Indium In-111 Chloride is a diagnostic radiopharmaceutical agent intended for radiolabeling OncoScint (satumomab pendetide) or ProstaScint (capromab pendetide) used for in vivo diagnostic imaging procedures and for radiolabeling Zevalin (ibritumomab tiuxetan) in preparations used for radioimmunotherapy procedures. It is supplied as a sterile, pyrogen-free solution of Indium (“‘In) Chloride in O.04M HCI. Its therapeutic use is listed as diagnostic agents. The directory classifies it as a commercial API with a mineral/inorganic source/manufacturing origin. Other names for this substance include Indiclor, Indium In 111 chloride and 111Indium trichloride. Its PubChem CID is 49800058.
Indium chloride in-111
| CAS No | 50800-85-6 |
|---|---|
| Molecular Formula | Cl3In |
| Molecular Weight | 217.26 g/mol |
| Synonyms | trichloro(111In)indigane |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Indium In-111 Chloride is a diagnostic radiopharmaceutical agent intended for radiolabeling OncoScint (satumomab pendetide) or ProstaScint (capromab pendetide) used for in vivo diagnostic imaging procedures and for radiolabeling Zevalin (ibritumomab tiuxetan) in preparations used for radioimmunotherapy procedures.
The listed CAS number is 50800-85-6.
The listed molecular formula is Cl3In.
The listed molecular weight is 217.26 g/mol.
trichloro(111In)indigane.
The source lists Indiclor, Indium In 111 chloride and 111Indium trichloride.